Atlas Trials

Efficacy of Lenalidomide in Combination With Subcutaneous Rituximab + miniCHOP in DLBCL Patients of 80 y/o or+

Clinical trial NCT02128061 · COMPLETED

Trial details

NCT number
NCT02128061
Sponsor
The Lymphoma Academic Research Organisation
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diffuse Large B Cell Lymphoma
Start date
2014-08-01
Primary completion
2018-11-05
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.